Birgit Rami-Merhar is an associate Professor of Pediatrics at the Medical University of Vienna, Austria. She leads the team for pediatric diabetology. She has been working in the field of pediatric diabetology for 25 years now, working closely and actively with national and international associations, such as ISPAD, SWEET, DPV, ENDO-ERN. Her research focus is within epidemiology, diabetes technology, long term prognosis of type 1 diabetes mellitus, complications, psychosocial factors, rare forms of diabetes mellitus, congenital hyperinsulinism, ß-cell-functions, Vascular complications in diabetes, insulins, hypoglycemia in T1D patients. Recent projects: KidsAP, INNODIA, INNODIA-MELD-ATG, DPV-Registry, SWEET Project, EURODIAB Her aim is to provide and improve care and quality of life for children and adolescents with diabetes mellitus. This also involves cooperations with diabetes lay organizations e.g. diabetes camps, diabetes education or family weekends. She has also been an author of national and international diabetes guidelines. A special interest covers the area of diabetes technology and the progress in the development and research in the pediatric field, especially in very young children.

Alexandria Ratzki-Leewing Schulich School of Medicine & Dentistry, Western University, London, ON, Canada Alexandria Ratzki-Leewing is the Lead Epidemiologist of the Diabetes Alliance Hypoglycemia Research Program at Western University’s Schulich School of Medicine & Dentistry, Canada. Over the past several years, she has been involved in and directed numerous national and international studies on the real-world clinical and behavioral epidemiology of diabetes-related hypoglycemia. Alexandria’s research focuses on the generation of patient-centered evidence relevant to the discovery of novel, yet pragmatic, interventional targets. Currently, she is a co-Principal Investigator of one of the world’s largest prospective investigations of hypoglycemia risk stratification (iNPHORM, USA) and COVID-19 (iNPHORM COVID-19) in diabetes. She also heads a nationwide hypoglycemia study in Canada (InHypo-DM). Alexandria has published widely and presented on various hypoglycemia topics around the world. She is known for her ability to educate diverse audiences on applied diabetes epidemiology.

Michal Rein, a registered dietitian, specializing in dietary interventions and modifications. Currently pursuing a PhD under joint supervision of Prof. Eran Segal from the Weizmann Institute of Science and Prof Shira Zelber-Sagi from the University of Haifa. As part of my research, I lead studies observing the effect of personally tailored diets by predictions of glycemic responses aimed to improve glycemic status and other metabolic parameters in various populations (such as healthy individuals, subjects with glucose intolerance and breast cancer survivors). Additionally, I am a part of an ongoing research integrating the data of dietary intake, personal characteristics, microbiome features and omics data on the influences of the individual reaction to glucose and other health indicators.

Eric Renard is Chair and Professor of Endocrinology, Diabetes and Metabolism at the University of Montpellier, France, since 1999. He also leads the Department of Endocrinology, Diabetes and Nutrition at Montpellier University Hospital and is Head of the INSERM Clinical Research Centre at Montpellier University Hospital. Eric Renard is also co-leader of a research team on “Innovative therapeutics for diabetes: understanding and correction of insulin secretion dysfunction and loss” at the Institute of Functional Genomics affiliated to CNRS, INSERM and the University of Montpellier. Professor Renard received his medical degree (Montpellier Medical School, 1987), completed a Research Fellowship at Joslin Diabetes Center (Harvard Medical School, Boston, USA, 1992), and received his PhD in Biochemistry & Molecular Biology (University of Montpellier, 1995). Professor Renard devoted his research work to the development of innovative technologies aiming at a physiological delivery of insulin for the therapy of diabetes mellitus, including wearable and implantable insulin pumps, intra-peritoneal insulin delivery, continuous glucose monitoring and closed-loop insulin delivery systems. His research activity has been supported by grants from the Juvenile Diabetes Research Fundation, the European Commission, the French Ministry of Health, and the American National Institute of Health. Eric Renard authored more than 280 peer-reviewed papers.

Founder, Sensotrend Oy. Mikael is a computer scientist and has lived with type 1 diabetes since 1999. First 10 years he was frustrated with the software available to record and interpret the data required to make sense of glucose levels, the past 10 years he has been passionate to make a difference. Sensotrend’s services provide actionable insights enriching glucose data with information from wellness apps like activity trackers and meal logging apps. Sensotrend’s services, CE marked as medical devices, also bring data from Nightscout apps into regulated healthcare systems. Sensotrend also specializes in integrating services to electronic health record systems, so that all the relevant information is available for healthcare professionals with a click of a button. Literally.